Drug search by name

Carfilzomib Intravenous and TTP/HUS

Result of checking the interaction of drug Carfilzomib Intravenous and disease TTP/HUS for safety when used together.

Check result:

Carfilzomib Intravenous <> TTP/HUS

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

Cases of thrombotic microangiopathy, including thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS) have been reported with the use of carfilzomib. Monitor for signs and symptoms of TTP/HUS. If the diagnosis is suspected, stop therapy and evaluate patients. If the diagnosis of TTP/HUS is excluded, therapy may be restarted. The safety of reinitiating carfilzomib therapy in patients previously experiencing TTP/HUS is not known.

Carfilzomib Intravenous

Generic Name: carfilzomib

Brand Name: Kyprolis

Synonyms: Carfilzomib

What is Carfilzomib Intravenous?